Pharmacolog announces the appointment of Anders Hedlund as interim CEO
NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)
Pharmacolog provides update on new business direction and proposes name change
Pharmacolog announces upcoming change in management
Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million
Major shareholder in Pharmacolog exercises warrants of series TO3 for at least approximately SEK 0.54 million
The last day of trading with warrants of series TO3 in Pharmacolog is today, February 20, 2024
Year-end bulletin Pharmacolog 2023
Pharmacolog investigates the possibilities for a new business direction
Pharmacolog terminates the partnership agreement with Codonics with immediate effect
The website uses necessary cookies to ensure the website functions properly. You can also choose to consent to cookies for statistical purposes.
Search
By requesting this documentation I agree to the terms in Pharmacologs privacy policy
